Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer.
CONCLUSIONS: Statin use in metastatic prostate cancer patients appears to delay the progression to CRPC. Large-scale, long-term follow-up studies are needed to validate this finding.
PMID: 26366275 [PubMed - in process]
Source: Korean Journal of Urology - Category: Urology & Nephrology Tags: Korean J Urol Source Type: research
More News: Cancer | Cancer & Oncology | Cholesterol | Diabetes | Endocrinology | Prostate Cancer | Statin Therapy | Study | Urology & Nephrology